October 25, 2016
4 min watch
Save

VIDEO: Analysis shows earlier, more aggressive treatment may be needed in persistent DME

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

CHICAGO — At the American Academy of Ophthalmology meeting here, SriniVas R. Sadda, MD, discusses a post hoc DRCR.net Protocol I study analysis of persistent macular edema in patients undergoing anti-VEGF therapy for diabetic macular edema.

The study showed that patients with more persistent macular edema at 1, 2 and 3 years had worse vision and may require more intensive treatment options earlier in the process.